Results 91 to 100 of about 2,583,576 (275)

The Use of Primary Care Physiotherapy for Persons With Bleeding Disorders in the Netherlands–A Retrospective Study of Health Records

Haemophilia, EarlyView.
ABSTRACT Introduction Patients with musculoskeletal complaints as a result of their bleeding disorder can benefit from primary care physiotherapy. The current study aims to describe physiotherapy services provided in primary care to patients with bleeding disorders and to what extent treatment was already in concordance with treatment recommendations ...
Johan Blokzijl, Martijn F. Pisters, Cindy Veenhof, Roger E. G. Schutgens, Merel A. Timmer   +4 more
wiley   +1 more source

Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States

Journal of Blood Medicine, 2022
Yanyu Wu,1 Shawn X Sun,1 Tao Fan2 1Global Evidence & Outcomes, Data Sciences Institute, Research and Development, Takeda Development Center Americas, Inc, Cambridge, MA, USA; 2US Health Economics and Outcomes Research, Takeda Pharmaceuticals USA, Inc ...
Wu Y, Sun SX, Fan T
doaj  

Compact Subsets of the Glimm Space of a $C^*$-algebra [PDF]

arXiv, 2012
If $A$ is a $\sigma$-unital $C^*$-algebra and $a$ is a strictly positive element of $A$ then for every compact subset $K$ of the complete regularization $\mathrm{Glimm}(A)$ of $\mathrm{Prim}(A)$ there exists $\alpha > 0$ such that $K\subset \{G\in \mathrm{Glimm}(A) \mid \|a + G\|\geq \alpha\}$. This extends a 1974 result of J.
arxiv  

Plasma Transfusions in Hemophilia [PDF]

, 1952
S. Van Creveld, M.M.P. Paulssen
openalex   +1 more source

Acquired hemophilia A

Hematology, 2006
Acquired hemophilia A is a rare but severe autoimmune bleeding disorder, resulting from the presence of autoantibodies directed against clotting factor VIII. The etiology of the disorder remains obscure, although approximately half of all cases are associated with other underlying conditions.
openaire   +3 more sources

Are Women Welcome in Haemophilia Trials?

Haemophilia, EarlyView.
Meaghan Jane O'Donnell, Rezan Abdul Kadir, Karin P. M. van Galen, Michelle Lavin, the EAHAD Women and Girls Working Group   +4 more
wiley   +1 more source

Subjective Physical Performance and Its Determinants in Patients With Haemophilia

Haemophilia, EarlyView.
ABSTRACT Introduction Physical functioning is compromised in patients with haemophilia (PwH). However, factors negatively influencing subjective physical performance (SPP) remain underexplored. Hence, this study aimed to compare the SPP of PwH with healthy controls (CON), to differentiate them based on disease‐specific, person‐related, and arthropathy ...
Alexander Schmidt, Fabian Tomschi, Pia Möllers, Marius Brühl, Sylvia von Mackensen, Andreas C. Strauss, Heinrich Richter, Johannes Oldenburg, Thomas Hilberg   +8 more
wiley   +1 more source

Hemophilia treatment and transfusion medicine

Zhongguo shuxue zazhi
The improvement of hemophilia treatment is attributed to the development of transfusion medicine, and the discovery of cryoprecipitate has opened up a new era of hemophilia treatment, laying the foundation for the development of modern hemophilia ...
FANG Yunhai, CHENG Yan, ZHANG Xinsheng
doaj   +1 more source

Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?

The Application of Clinical Genetics, 2022
Werasak Sasanakul, Ampaiwan Chuansumrit, Nongnuch Sirachainan, Praguywan Kadegasem Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Ampaiwan Chuansumrit, Department of Pediatrics ...
Sasanakul W, Chuansumrit A, Sirachainan N, Kadegasem P   +3 more
doaj  

A Bayesian Approach for Selecting Relevant External Data (BASE): Application to a study of Long-Term Outcomes in a Hemophilia Gene Therapy Trial [PDF]

arXiv
Gene therapies aim to address the root causes of diseases, particularly those stemming from rare genetic defects that can be life-threatening or severely debilitating. Although an increasing number of gene therapies have received regulatory approvals in recent years, understanding their long-term efficacy in trials with limited follow-up time remains ...
arxiv